USD 31.29
(1.45%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 6.56 Billion USD | 1.5% |
2023 | 6.47 Billion USD | -0.43% |
2022 | 6.49 Billion USD | 9.93% |
2021 | 5.91 Billion USD | 7.69% |
2020 | 5.49 Billion USD | -1.52% |
2019 | 5.57 Billion USD | 1.99% |
2018 | 5.46 Billion USD | -2.28% |
2017 | 5.59 Billion USD | 3.83% |
2016 | 5.38 Billion USD | 23.12% |
2015 | 4.37 Billion USD | 7.66% |
2014 | 4.06 Billion USD | 11.73% |
2013 | 3.63 Billion USD | 2.87% |
2012 | 3.53 Billion USD | 3.51% |
2011 | 3.41 Billion USD | 5.51% |
2010 | 3.23 Billion USD | 4.63% |
2009 | 3.09 Billion USD | 3.18% |
2008 | 2.99 Billion USD | 7.16% |
2007 | 2.79 Billion USD | 7.01% |
2006 | 2.61 Billion USD | 8.0% |
2005 | 2.42 Billion USD | 22.96% |
2004 | 1.96 Billion USD | 18.85% |
2003 | 1.65 Billion USD | 17.06% |
2002 | 1.41 Billion USD | 22.4% |
2001 | 1.15 Billion USD | 11.16% |
2000 | 1.04 Billion USD | 18.38% |
1999 | 878.8 Million USD | 12.93% |
1998 | 778.2 Million USD | 17.64% |
1997 | 661.5 Million USD | 13.68% |
1996 | 581.9 Million USD | 9.26% |
1995 | 532.6 Million USD | 14.07% |
1994 | 466.9 Million USD | 36.2% |
1993 | 342.8 Million USD | 23.71% |
1992 | 277.1 Million USD | 13.99% |
1991 | 243.1 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 1.57 Billion USD | -8.39% |
2024 FY | 6.56 Billion USD | 1.5% |
2024 Q4 | 1.72 Billion USD | 6.59% |
2024 Q3 | 1.61 Billion USD | -2.22% |
2024 Q2 | 1.65 Billion USD | 4.82% |
2023 Q2 | 1.62 Billion USD | 6.76% |
2023 Q3 | 1.6 Billion USD | -1.56% |
2023 Q1 | 1.52 Billion USD | -7.05% |
2023 FY | 6.47 Billion USD | -0.43% |
2023 Q4 | 1.72 Billion USD | 7.51% |
2022 Q1 | 1.61 Billion USD | 3.4% |
2022 FY | 6.49 Billion USD | 9.93% |
2022 Q4 | 1.63 Billion USD | 2.64% |
2022 Q3 | 1.59 Billion USD | -3.19% |
2022 Q2 | 1.64 Billion USD | 2.12% |
2021 FY | 5.91 Billion USD | 7.69% |
2021 Q1 | 1.24 Billion USD | -3.16% |
2021 Q4 | 1.56 Billion USD | 0.68% |
2021 Q3 | 1.55 Billion USD | -0.12% |
2021 Q2 | 1.55 Billion USD | 24.67% |
2020 Q4 | 1.28 Billion USD | -11.65% |
2020 Q2 | 1.41 Billion USD | 6.78% |
2020 FY | 5.49 Billion USD | -1.52% |
2020 Q1 | 1.32 Billion USD | -7.52% |
2020 Q3 | 1.45 Billion USD | 2.64% |
2019 Q1 | 1.33 Billion USD | -4.59% |
2019 FY | 5.57 Billion USD | 1.99% |
2019 Q2 | 1.4 Billion USD | 5.12% |
2019 Q3 | 1.39 Billion USD | -0.57% |
2019 Q4 | 1.43 Billion USD | 2.86% |
2018 Q3 | 1.37 Billion USD | -0.76% |
2018 Q1 | 1.3 Billion USD | -9.75% |
2018 Q2 | 1.38 Billion USD | 6.26% |
2018 Q4 | 1.4 Billion USD | 1.85% |
2018 FY | 5.46 Billion USD | -2.28% |
2017 Q2 | 1.41 Billion USD | 6.44% |
2017 FY | 5.59 Billion USD | 3.83% |
2017 Q4 | 1.44 Billion USD | 3.41% |
2017 Q3 | 1.39 Billion USD | -1.47% |
2017 Q1 | 1.33 Billion USD | -8.35% |
2016 FY | 5.38 Billion USD | 23.12% |
2016 Q4 | 1.45 Billion USD | 3.78% |
2016 Q2 | 1.38 Billion USD | 21.55% |
2016 Q3 | 1.4 Billion USD | 0.84% |
2016 Q1 | 1.14 Billion USD | -0.52% |
2015 Q3 | 1.06 Billion USD | -3.63% |
2015 Q2 | 1.1 Billion USD | 4.13% |
2015 Q4 | 1.14 Billion USD | 8.04% |
2015 FY | 4.37 Billion USD | 7.66% |
2015 Q1 | 1.05 Billion USD | -3.86% |
2014 Q4 | 1.1 Billion USD | 1.79% |
2014 Q2 | 998.83 Million USD | 13.49% |
2014 Q1 | 880.12 Million USD | -8.79% |
2014 FY | 4.06 Billion USD | 11.73% |
2014 Q3 | 1.08 Billion USD | 8.39% |
2013 Q3 | 915.86 Million USD | 5.61% |
2013 Q2 | 867.19 Million USD | -2.48% |
2013 Q1 | 889.22 Million USD | -5.03% |
2013 FY | 3.63 Billion USD | 2.87% |
2013 Q4 | 964.93 Million USD | 5.36% |
2012 FY | 3.53 Billion USD | 3.51% |
2012 Q1 | 847.42 Million USD | -4.12% |
2012 Q2 | 856.87 Million USD | 1.12% |
2012 Q3 | 895.03 Million USD | 4.45% |
2012 Q4 | 936.33 Million USD | 4.61% |
2011 Q3 | 824.65 Million USD | -3.82% |
2011 Q1 | 849.78 Million USD | 4.56% |
2011 Q2 | 857.41 Million USD | 0.9% |
2011 Q4 | 883.81 Million USD | 7.18% |
2011 FY | 3.41 Billion USD | 5.51% |
2010 Q4 | 812.76 Million USD | -0.89% |
2010 Q1 | 789.57 Million USD | 1.24% |
2010 FY | 3.23 Billion USD | 4.63% |
2010 Q3 | 820.08 Million USD | 0.63% |
2010 Q2 | 814.95 Million USD | 3.21% |
2009 Q3 | 811.02 Million USD | 6.79% |
2009 FY | 3.09 Billion USD | 3.18% |
2009 Q1 | 743.85 Million USD | -4.44% |
2009 Q2 | 759.46 Million USD | 2.1% |
2009 Q4 | 779.88 Million USD | -3.84% |
2008 FY | 2.99 Billion USD | 7.16% |
2008 Q1 | 701.4 Million USD | -5.11% |
2008 Q2 | 741.99 Million USD | 5.79% |
2008 Q3 | 776.94 Million USD | 4.71% |
2008 Q4 | 778.38 Million USD | 0.19% |
2007 Q4 | 739.14 Million USD | 4.18% |
2007 Q1 | 655.48 Million USD | -5.71% |
2007 Q2 | 694.27 Million USD | 5.92% |
2007 FY | 2.79 Billion USD | 7.01% |
2007 Q3 | 709.49 Million USD | 2.19% |
2006 Q4 | 695.17 Million USD | 1.87% |
2006 Q3 | 682.4 Million USD | 6.34% |
2006 Q2 | 641.69 Million USD | 7.69% |
2006 Q1 | 595.84 Million USD | -5.01% |
2006 FY | 2.61 Billion USD | 8.0% |
2005 FY | 2.42 Billion USD | 22.96% |
2005 Q4 | 627.27 Million USD | -1.68% |
2005 Q3 | 638 Million USD | 10.34% |
2005 Q2 | 578.23 Million USD | 0.05% |
2005 Q1 | 577.94 Million USD | 7.55% |
2004 FY | 1.96 Billion USD | 18.85% |
2004 Q4 | 537.35 Million USD | 3.1% |
2004 Q2 | 477.51 Million USD | 10.21% |
2004 Q3 | 521.21 Million USD | 9.15% |
2004 Q1 | 433.26 Million USD | -3.14% |
2003 FY | 1.65 Billion USD | 17.06% |
2003 Q1 | 387.73 Million USD | -3.03% |
2003 Q2 | 400.82 Million USD | 3.37% |
2003 Q3 | 421.07 Million USD | 5.05% |
2003 Q4 | 447.32 Million USD | 6.24% |
2002 Q1 | 303.25 Million USD | -2.3% |
2002 Q4 | 399.84 Million USD | 11.88% |
2002 Q3 | 357.39 Million USD | 0.67% |
2002 Q2 | 355.01 Million USD | 17.07% |
2002 FY | 1.41 Billion USD | 22.4% |
2001 Q3 | 288.89 Million USD | 0.01% |
2001 Q2 | 288.87 Million USD | 7.67% |
2001 FY | 1.15 Billion USD | 11.16% |
2001 Q1 | 268.29 Million USD | -3.19% |
2001 Q4 | 310.39 Million USD | 7.45% |
2000 Q1 | 254.6 Million USD | 8.25% |
2000 Q4 | 277.14 Million USD | 6.51% |
2000 Q2 | 248.4 Million USD | -2.44% |
2000 FY | 1.04 Billion USD | 18.38% |
2000 Q3 | 260.2 Million USD | 4.75% |
1999 Q2 | 213.3 Million USD | 6.6% |
1999 Q1 | 200.1 Million USD | -5.17% |
1999 Q4 | 235.2 Million USD | 2.17% |
1999 Q3 | 230.2 Million USD | 7.92% |
1999 FY | 878.8 Million USD | 12.93% |
1998 Q1 | 173.3 Million USD | -4.47% |
1998 Q3 | 195.5 Million USD | 2.04% |
1998 Q2 | 191.6 Million USD | 10.56% |
1998 FY | 778.2 Million USD | 17.64% |
1998 Q4 | 211 Million USD | 7.93% |
1997 Q4 | 181.4 Million USD | 3.01% |
1997 Q2 | 161.9 Million USD | 13.85% |
1997 Q1 | 142.2 Million USD | -8.38% |
1997 FY | 661.5 Million USD | 13.68% |
1997 Q3 | 176.1 Million USD | 8.77% |
1996 Q4 | 155.2 Million USD | 4.37% |
1996 FY | 581.9 Million USD | 9.26% |
1996 Q3 | 148.7 Million USD | 3.48% |
1996 Q2 | 143.7 Million USD | 7.0% |
1996 Q1 | 134.3 Million USD | -4.41% |
1995 Q2 | 131.9 Million USD | 6.72% |
1995 Q3 | 136.5 Million USD | 3.49% |
1995 Q4 | 140.5 Million USD | 2.93% |
1995 FY | 532.6 Million USD | 14.07% |
1995 Q1 | 123.6 Million USD | -2.22% |
1994 Q3 | 124.9 Million USD | 9.66% |
1994 Q4 | 126.4 Million USD | 1.2% |
1994 FY | 466.9 Million USD | 36.2% |
1994 Q1 | 101.8 Million USD | 14.13% |
1994 Q2 | 113.9 Million USD | 11.89% |
1993 Q4 | 89.2 Million USD | 4.82% |
1993 FY | 342.8 Million USD | 23.71% |
1993 Q1 | 81.9 Million USD | 9.2% |
1993 Q2 | 86.6 Million USD | 5.74% |
1993 Q3 | 85.1 Million USD | -1.73% |
1992 Q4 | 75 Million USD | 8.7% |
1992 FY | 277.1 Million USD | 13.99% |
1992 Q1 | 63.3 Million USD | -3.51% |
1992 Q2 | 69.8 Million USD | 10.27% |
1992 Q3 | 69 Million USD | -1.15% |
1991 FY | 243.1 Million USD | 0.0% |
1991 Q1 | 57.4 Million USD | 0.0% |
1991 Q2 | 60.6 Million USD | 5.57% |
1991 Q3 | 59.6 Million USD | -1.65% |
1991 Q4 | 65.6 Million USD | 10.07% |
Name | Revenue | Revenue Difference |
---|---|---|
Phreesia, Inc. | 356.29 Million USD | -1743.472% |
Accuray Incorporated | 446.55 Million USD | -1370.89% |
Align Technology, Inc. | 3.86 Billion USD | -70.063% |
Elevance Health Inc. | 171.34 Billion USD | 96.167% |
AxoGen, Inc. | 159.01 Million USD | -4030.677% |
Boston Scientific Corporation | 14.24 Billion USD | 53.874% |
CVS Health Corporation | 357.77 Billion USD | 98.164% |
Cardinal Health, Inc. | 226.82 Billion USD | 97.104% |
Centene Corporation | 141.26 Billion USD | 95.35% |
DaVita Inc. | 12.14 Billion USD | 45.896% |
HCA Healthcare, Inc. | 64.96 Billion USD | 89.89% |
Hologic, Inc. | 4.03 Billion USD | -62.972% |
Humana Inc. | 106.37 Billion USD | 93.825% |
IDEXX Laboratories, Inc. | 3.66 Billion USD | -79.414% |
Laboratory Corporation of America Holdings | 12.16 Billion USD | 45.992% |
Masimo Corporation | 2.04 Billion USD | -220.701% |
McKesson Corporation | 308.95 Billion USD | 97.874% |
Quest Diagnostics Incorporated | 9.25 Billion USD | 29.007% |
ResMed Inc. | 4.68 Billion USD | -40.189% |
Henry Schein, Inc. | 12.33 Billion USD | 46.768% |
Teladoc Health, Inc. | 2.6 Billion USD | -152.391% |
Universal Health Services, Inc. | 14.28 Billion USD | 54.01% |
Veeva Systems Inc. | 2.36 Billion USD | -177.884% |
Baxter International Inc. | 14.81 Billion USD | 55.659% |
Becton, Dickinson and Company | 19.37 Billion USD | 66.094% |
Intuitive Surgical, Inc. | 7.12 Billion USD | 7.802% |
Danaher Corporation | 23.89 Billion USD | 72.506% |
Stryker Corporation | 20.49 Billion USD | 67.957% |
Medtronic plc | 32.36 Billion USD | 79.705% |